2018 Executive Sponsors
2018 Associate Sponsors
2018 Exhibiting Companies
2018 Supporting Sponsors
2018 Supporting Partners
2018 Media Partners
2018 Supporting Partners
The All of Us Research Program has a simple mission. They want to speed up health research breakthroughs. To do this, they’re asking one million people to share health information. In the future, researchers can use this to conduct thousands of health studies. Stop by their booth to find out how pharma stands to benefit and if you want to join or just learn more at www.joinallofus.org.
The Center for Information and Study on Clinical Research Participation (CISCRP) was founded in 2003, and is a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. As part of its mission, CISCRP provides a variety of award-winning resources, programs and services that are designed to assist clinical research stakeholders in understanding public and patient attitudes and experiences in research as well as improving volunteer participation experiences and satisfaction. Visit www.ciscrp.org.
Our mission is to highlight the heroic work of clinical trial participation and increase patient engagement in clinical trials by gifting a child in need with a potentially life-saving vaccine in honor of every clinical trial volunteer and every clinical research professional who make advancing global health possible. Since 2010, Greater Gift has donated over 100,000 vaccines to people in need, worldwide, as a way to give back and thank the volunteers and professionals who participate in clinical trials. But there is more work to be done. Our vision is to donate over 500,000 gifts by 2020 while thanking the clinical trial participants and contributors who make medicine possible. You too can make our vision possible. Donate today. Learn more at www.greatergift.org.
Patient Empowerment Network is a non-profit organization dedicated to empowering cancer patients through education and support. We help patients gain the confidence and knowledge to become advocates for themselves and for those in their cancer community. We are here to help them stand up and ask for the best care for themselves. We are here to help them seek out the medical team that is best for them, give them confidence to ask their team about new treatment options, including clinical trials and to help them cope and live well with their illness. Patient Empowerment Network focuses on blood cancers (chronic lymphocytic leukemia, multiple myeloma and myeloproliferative neoplasms), and lung cancer and prostate cancer. For more, see our website here: www.powerfulpati
Wondros offers strategic consulting and a full suite of creative services for clients at the cutting edge of business, health care, philanthropy, public policy, and the arts. Learn more at www.wondros.com.
2018 Media Partners
Big3Bio provides coverage of the developments about and within the life science industry’s “Big 3” regions: Boston, the San Francisco Bay Area and San Diego. Our mission is to fulfill stakeholders’ needs for invaluable industry information by researching thousands of sources every day and sharing that coverage with our subscribers each morning via our free daily regional newsletters – Big3Bio:Boston, Big3Bio:SFBay and Big3Bio:San Diego.
BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousands of healthcare data points, aggregated into one centralized source. In addition to the proprietary articles, BioPharm Insight is currently tracking 500,000 management and R&D contacts, 7,500 biopharma companies with full pipeline data, 120,000 investigational and approved drug profiles, 28,000 M&A and licensing deals, 10,000 extended sales forecasts and epidemiology profiles for hundreds of indications. To learn more, visit www.biopharminsight.com and follow us on Twitter @BioPharmInsight
Life Science Leader magazine, a product of the Life Science Connect Media Group, strives to be an essential business tool for life science executives. As such, our content is designed to not only inform readers of industry best practices, but to motivate them to implement those best practices in their own businesses. Each month, Life Science Leader features interviews of executives from the leading pharm and biotech companies, including Merck, Daiichi Sankyo, Genentech, Biogen Idec, Allergan, Pfizer, MedImmune, Genzyme, Eli Lilly, Janssen, the FDA, and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharmaceutical and biopharmaceutical markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes. Our monthly columns include “Companies to Watch,” “Capital Perspectives,” “Outsourcing Reports,” “Leadership Lessons,” and “Industry Insights.” Learn more at www.lifescienceleader.com.
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc. Learn more at www.pharmalicensing.com.
We are a content and communications company offering a unique hybrid combination of publishing heritage and journalism and the creativity and expertise of an agency. pharmaphorum.com is a leading destination for news and information for pharma professionals, serving 300k of them every month as a Google-recognized source of “real” news and information. As an agency team at pharmaphorum connect, we work with global pharma companies to apply this expertise in publishing, journalism and content-development to deliver research-based, content-driven and socially-amplified customer engagement.
SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals – Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications online. For more details regarding SciDoc Publishers, visit www.scidoc.org.
STAT is a national publication that delivers fast, deep, and tough-minded journalism about life sciences and the fast-moving business of making medicines. We take you inside academic labs, biotech boardrooms, and political backrooms. With an award-winning newsroom, STAT gives you indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life science industry — and a revolution in human health. These are the stories that matter to us all. Learn more about www.statnews.com.
Technology Networks is an internationally recognized publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas. Visit www.technologynetworks.com.
TrialSite News was formed to aggregate translational, pre-clinical, and clinical trial news every day. We are the only news site that focuses on research from a research site (center) and investigator/researcher perspective. We seek to bring awareness and transparency to clinical research with a special emphasis on sites and investigative staff. Our platform not only aggregates daily news but also may be leveraged to bring together sponsors, sites, and staff, as well as those interested in clinical research for interactive digital engagement opportunities. Learn more at www.trialsitenews.com.
We enjoy collaborating with the media. If you are interested in becoming a media partner, please contact:
email@example.com | 646-350-2580